PIOLAX (5988) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
5 Aug, 2026Executive summary
Net sales for the quarter ended June 30, 2026, rose 4.4% year-over-year to ¥15,761 million, with operating profit down 30.5% to ¥266 million and ordinary profit up 28.5% to ¥394 million.
Profit attributable to owners of parent was ¥125 million, a 2.0% decrease year-over-year.
Comprehensive income improved significantly to ¥863 million from a loss of ¥2,008 million in the prior year period.
Financial highlights
Gross profit increased to ¥3,392 million from ¥3,264 million year-over-year.
Basic earnings per share rose to ¥5.21 from ¥4.65 year-over-year.
Total assets as of June 30, 2026, were ¥100,182 million, with net assets at ¥65,372 million and an equity-to-asset ratio of 64.0%.
Cash and deposits stood at ¥26,160 million at quarter-end.
Outlook and guidance
Fiscal year ending March 31, 2027, is forecasted to see net sales of ¥63,000 million (up 1.5% year-over-year), operating profit of ¥1,500 million (up 2.0%), and profit attributable to owners of parent of ¥700 million.
Annual dividend forecast is ¥92.00 per share.
Latest events from PIOLAX
- Profits fell sharply with a net loss, but FY2027 guidance expects a return to profitability.5988
Q4 202612 May 2026 - Sales up 3.2% but profits down; focus on CASE, global growth, and capital returns.5988
Q2 202516 Mar 2026 - Profits and sales fell sharply, but long-term growth targets and strong shareholder returns remain.5988
Q4 202516 Mar 2026 - Sales rose but profits fell on higher costs; full-year profit forecast remains lower.5988
Q1 202516 Mar 2026 - Net income fell 52% year-over-year as sales and profitability declined, with guidance unchanged.5988
Q3 202516 Mar 2026 - Profits and sales fell sharply, prompting strategic focus on innovation and cost control.5988
Q2 202616 Mar 2026 - Profits and comprehensive income fell sharply, with a cautious outlook for the full year.5988
Q1 202616 Mar 2026 - Profits and comprehensive income fell sharply, but a moderate recovery is forecasted.5988
Q3 202616 Mar 2026